Identification of LAMP2 as the direct target of aloperine derivatives for degrading PD-L1 through the lysosomal pathway based on deep learning model

  • Bioorg Chem. 2026 May 28:180:110056. doi: 10.1016/j.bioorg.2026.110056.
Runze Meng  1 Xintong Zhang  1 Xijun Zhong  1 Yanhong Li  1 Zhiyun Wu  1 Zhihui Yu  1 Jiaqi Liang  1 Hongbin Deng  1 Xican Ma  1 Yinghong Li  2 Danqing Song  3
Affiliations
  • 1. State Key Laboratory of Bioactive Substances and Function of Natural Medicines, Institute of Medicinal Biotechnology, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100050, China.
  • 2. State Key Laboratory of Bioactive Substances and Function of Natural Medicines, Institute of Medicinal Biotechnology, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100050, China. Electronic address: [email protected].
  • 3. State Key Laboratory of Bioactive Substances and Function of Natural Medicines, Institute of Medicinal Biotechnology, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100050, China. Electronic address: [email protected].
Abstract

Aloperine derivatives can promote the degradation of PD-L1 through different pathways and elicit antitumor immunity, but their direct targets remain unclear. In this study, 30 aloperine derivatives were synthesized and screened for their efficacy in reducing PD-L1 levels, and compound 7a was found to effectively promote PD-L1 degradation through the lysosomal pathway. Then, based on the DeepDTAGen deep learning model, lysosome-associated membrane protein 2 (LAMP2) was predicted to be a potential functional target of 7a. Multiple biochemical assays demonstrated that 7a induced PD-L1 degradation through the LAMP2-mediated lysosomal pathway, with a KD value of 5.58 μM. Furthermore, molecular docking and molecular dynamics simulations proposed a plausible binding mode of 7a with LAMP2. Therefore, the integrated computational-experimental strategy efficiently identified LAMP2 as a direct-binding functional target of 7a for the degradation of PD-L1 via lysosomal pathway, providing a reference case for the rapid discovery of target.

Keywords
Aloperine; Deep learning; LAMP2; Lysosomal pathway; PD-L1.
Products